- Previous Close
19.25 - Open
19.23 - Bid 19.25 x 1100
- Ask 19.33 x 900
- Day's Range
19.26 - 19.71 - 52 Week Range
17.73 - 77.69 - Volume
40,579 - Avg. Volume
294,450 - Market Cap (intraday)
211.923M - Beta (5Y Monthly) 1.16
- PE Ratio (TTM)
7.23 - EPS (TTM)
2.68 - Earnings Date Nov 4, 2024 - Nov 8, 2024
- Forward Dividend & Yield 6.60 (34.41%)
- Ex-Dividend Date Sep 18, 2023
- 1y Target Est
17.25
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
medifastinc.com634
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MED
View More
Performance Overview: MED
Trailing total returns as of 9/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MED
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MED
View MoreValuation Measures
Market Cap
210.55M
Enterprise Value
66.14M
Trailing P/E
7.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.27
Price/Book (mrq)
1.03
Enterprise Value/Revenue
0.09
Enterprise Value/EBITDA
1.40
Financial Highlights
Profitability and Income Statement
Profit Margin
3.81%
Return on Assets (ttm)
6.99%
Return on Equity (ttm)
15.01%
Revenue (ttm)
770.18M
Net Income Avi to Common (ttm)
29.33M
Diluted EPS (ttm)
2.68
Balance Sheet and Cash Flow
Total Cash (mrq)
163.5M
Total Debt/Equity (mrq)
9.30%
Levered Free Cash Flow (ttm)
18.05M
Research Analysis: MED
View MoreCompany Insights: MED
MED does not have Company Insights
Research Reports: MED
View MoreLowering target price to $21.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetLowering target price to $23.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $23.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetLowering target price to $25.00
MEDIFAST INC has an Investment Rating of HOLD; a target price of $25.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetWhat does Argus have to say about MED?
MEDIFAST INC has an Investment Rating of HOLD; a target price of $26.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target